Equities

Sera Prognostics Inc

SERA:NMQ

Sera Prognostics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)7.80
  • Today's Change-0.03 / -0.38%
  • Shares traded93.16k
  • 1 Year change+333.33%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sera Prognostics Inc grew revenues 14.18% from 268.00k to 306.00k while net income improved from a loss of 44.19m to a smaller loss of 36.24m.
Gross margin1.87%
Net profit margin-29,471.96%
Operating margin-33,067.29%
Return on assets-34.74%
Return on equity-44.77%
Return on investment-44.23%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Sera Prognostics Inc fell by 26.00m. Cash Flow from Financing totalled 752.00k or 245.75% of revenues. In addition the company used 27.19m for operations while cash from investing totalled 438.00k.
Cash flow per share-0.96
Price/Cash flow per share--
Book value per share1.79
Tangible book value per share1.77
More ▼

Balance sheet in USDView more

Sera Prognostics Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.70%.
Current ratio2.08
Quick ratio--
Total debt/total equity0.007
Total debt/total capital0.007
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.